Penirolol
| |
| Nazivi | |
|---|---|
| IUPAC naziv
2-(3-((1,1-dimethilpropil)amino)-2-hidroksipropoksi)-benzonitril
| |
| Drugi nazivi
Unii-bt9Y6D2dr0
2-(3-((1,1-dimethilpropil)amino)-2-hidroksipropoksi)-benzonitril | |
| Identifikacija | |
3D model (Jmol)
|
|
| ChemSpider | |
| UNII | |
| |
| Svojstva | |
| C15H22N2O2 | |
| Molarna masa | 262,35 g·mol−1 |
| Gustina | 1,07±0,1 g/cm3 (predviđeno) |
| Tačka ključanja | 426,1±35,0 °C (predviđeno) |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Penirolol je antagonist beta adrenergičkog receptora.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Hugues, FC; Julien, D; Bors, V; Mougeot, G; Marche, J (1980). „Determination in man of the beta blocking properties and the pharmacological half of pargolol (Author's transl)”. Thérapie. 35 (4): 475—81. PMID 6110251.